30,277 Shares in Lemonade, Inc. (NYSE:LMND) Purchased by Illumine Investment Management LLC

Illumine Investment Management LLC acquired a new position in shares of Lemonade, Inc. (NYSE:LMND) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 30,277 shares of the company’s stock, valued at approximately $1,111,000.

Several other hedge funds have also modified their holdings of LMND. Avior Wealth Management LLC purchased a new stake in shares of Lemonade during the 4th quarter worth approximately $40,000. Blue Trust Inc. raised its holdings in shares of Lemonade by 220.0% during the 3rd quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after acquiring an additional 1,879 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of Lemonade during the 4th quarter worth approximately $67,000. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Lemonade by 321.3% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,462 shares of the company’s stock valued at $74,000 after purchasing an additional 3,403 shares during the last quarter. Finally, KBC Group NV bought a new position in shares of Lemonade during the 4th quarter valued at approximately $80,000. 80.30% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Lemonade news, insider John Sheldon Peters sold 1,790 shares of Lemonade stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $45.50, for a total value of $81,445.00. Following the sale, the insider now owns 88,493 shares in the company, valued at $4,026,431.50. The trade was a 1.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Softbank Group Capital Ltd sold 7,067 shares of Lemonade stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $43.02, for a total value of $304,022.34. Following the completion of the sale, the insider now owns 10,699,211 shares in the company, valued at $460,280,057.22. This represents a 0.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 769,657 shares of company stock worth $33,868,724 over the last quarter. 12.50% of the stock is currently owned by corporate insiders.

Lemonade Trading Up 12.7 %

Shares of LMND opened at $35.47 on Friday. Lemonade, Inc. has a 12 month low of $14.03 and a 12 month high of $53.85. The stock’s 50 day moving average is $35.22 and its two-hundred day moving average is $29.23. The firm has a market cap of $2.53 billion, a P/E ratio of -11.67 and a beta of 2.15.

Lemonade (NYSE:LMND) last issued its quarterly earnings data on Tuesday, February 25th. The company reported ($0.42) EPS for the quarter, beating the consensus estimate of ($0.61) by $0.19. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. The company had revenue of $148.80 million for the quarter, compared to analyst estimates of $144.78 million. Equities research analysts forecast that Lemonade, Inc. will post -3.03 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on LMND. Morgan Stanley raised Lemonade from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $23.00 to $42.00 in a research report on Wednesday, November 20th. BMO Capital Markets upped their price objective on Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Thursday, November 21st. JMP Securities increased their price target on Lemonade from $40.00 to $60.00 and gave the stock a “market outperform” rating in a research report on Friday, November 22nd. Piper Sandler dropped their price target on Lemonade from $44.00 to $34.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, Keefe, Bruyette & Woods cut Lemonade from a “market perform” rating to an “underperform” rating and upped their price objective for the stock from $18.00 to $21.00 in a research note on Thursday, November 7th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Lemonade currently has an average rating of “Hold” and a consensus price target of $31.00.

Lemonade Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.